毛髪細胞白血病の治療世界市場の発展状況と動向 2024-2030
英文タイトル: Global Hairy cell Leukemia Treatment Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
サンプルお申込み
お問い合わせ
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は毛髪細胞白血病の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは毛髪細胞白血病の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界の毛髪細胞白血病の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは毛髪細胞白血病の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に毛髪細胞白血病の治療市場を分類しています。本研究に含まれる主な企業は:F. Hoffmann-La Roche、Janssen Global Services、Dr. Reddy's Laboratories、Emcure Pharmaceuticals、Amgen、Hospira、Astex Therapeutics、AbbVie、Astellas Pharma、AstraZeneca、Biogenomics
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Chemotherapy Drugs
Immunotherapy Drugs
用途別の市場セグメント:
Hospitals
Pharmacies
Cancer Research Organization
本レポートの詳細内容
世界の毛髪細胞白血病の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、毛髪細胞白血病の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の毛髪細胞白血病の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の毛髪細胞白血病の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、毛髪細胞白血病の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
毛髪細胞白血病の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:毛髪細胞白血病の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:毛髪細胞白血病の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章毛髪細胞白血病の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:毛髪細胞白血病の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:毛髪細胞白血病の治療の主要企業の概要を提供し、製品の説明と仕様、毛髪細胞白血病の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. Market Analysis and Insights: Global Hairy cell Leukemia Treatment Market The global Hairy cell Leukemia Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Report Covers: This report presents an overview of global market for Hairy cell Leukemia Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Hairy cell Leukemia Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hairy cell Leukemia Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Hairy cell Leukemia Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hairy cell Leukemia Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hairy cell Leukemia Treatment revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including F. Hoffmann-La Roche, Janssen Global Services, Dr. Reddy's Laboratories, Emcure Pharmaceuticals, Amgen, Hospira, Astex Therapeutics, AbbVie and Astellas Pharma, etc. Market Segmentation By Company F. Hoffmann-La Roche Janssen Global Services Dr. Reddy's Laboratories Emcure Pharmaceuticals Amgen Hospira Astex Therapeutics AbbVie Astellas Pharma AstraZeneca Biogenomics Segment by Type Chemotherapy Drugs Immunotherapy Drugs Segment by Application Hospitals Pharmacies Cancer Research Organization By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Hairy cell Leukemia Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Hairy cell Leukemia Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hairy cell Leukemia Treatment revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hairy cell Leukemia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chemotherapy Drugs
1.2.3 Immunotherapy Drugs
1.3 Market by Application
1.3.1 Global Hairy cell Leukemia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Cancer Research Organization
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hairy cell Leukemia Treatment Market Perspective (2019-2030)
2.2 Global Hairy cell Leukemia Treatment Growth Trends by Region
2.2.1 Hairy cell Leukemia Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hairy cell Leukemia Treatment Historic Market Size by Region (2019-2024)
2.2.3 Hairy cell Leukemia Treatment Forecasted Market Size by Region (2025-2030)
2.3 Hairy cell Leukemia Treatment Market Dynamics
2.3.1 Hairy cell Leukemia Treatment Industry Trends
2.3.2 Hairy cell Leukemia Treatment Market Drivers
2.3.3 Hairy cell Leukemia Treatment Market Challenges
2.3.4 Hairy cell Leukemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hairy cell Leukemia Treatment by Players
3.1.1 Global Hairy cell Leukemia Treatment Revenue by Players (2019-2024)
3.1.2 Global Hairy cell Leukemia Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Hairy cell Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hairy cell Leukemia Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Hairy cell Leukemia Treatment Market Concentration Ratio
3.4.1 Global Hairy cell Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hairy cell Leukemia Treatment Revenue in 2023
3.5 Global Key Players of Hairy cell Leukemia Treatment Head office and Area Served
3.6 Global Key Players of Hairy cell Leukemia Treatment, Product and Application
3.7 Global Key Players of Hairy cell Leukemia Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hairy cell Leukemia Treatment Breakdown Data by Type
4.1 Global Hairy cell Leukemia Treatment Historic Market Size by Type (2019-2024)
4.2 Global Hairy cell Leukemia Treatment Forecasted Market Size by Type (2025-2030)
5 Hairy cell Leukemia Treatment Breakdown Data by Application
5.1 Global Hairy cell Leukemia Treatment Historic Market Size by Application (2019-2024)
5.2 Global Hairy cell Leukemia Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hairy cell Leukemia Treatment Market Size (2019-2030)
6.2 North America Hairy cell Leukemia Treatment Market Size by Type
6.2.1 North America Hairy cell Leukemia Treatment Market Size by Type (2019-2024)
6.2.2 North America Hairy cell Leukemia Treatment Market Size by Type (2025-2030)
6.2.3 North America Hairy cell Leukemia Treatment Market Share by Type (2019-2030)
6.3 North America Hairy cell Leukemia Treatment Market Size by Application
6.3.1 North America Hairy cell Leukemia Treatment Market Size by Application (2019-2024)
6.3.2 North America Hairy cell Leukemia Treatment Market Size by Application (2025-2030)
6.3.3 North America Hairy cell Leukemia Treatment Market Share by Application (2019-2030)
6.4 North America Hairy cell Leukemia Treatment Market Size by Country
6.4.1 North America Hairy cell Leukemia Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Hairy cell Leukemia Treatment Market Size by Country (2019-2024)
6.4.3 North America Hairy cell Leukemia Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hairy cell Leukemia Treatment Market Size (2019-2030)
7.2 Europe Hairy cell Leukemia Treatment Market Size by Type
7.2.1 Europe Hairy cell Leukemia Treatment Market Size by Type (2019-2024)
7.2.2 Europe Hairy cell Leukemia Treatment Market Size by Type (2025-2030)
7.2.3 Europe Hairy cell Leukemia Treatment Market Share by Type (2019-2030)
7.3 Europe Hairy cell Leukemia Treatment Market Size by Application
7.3.1 Europe Hairy cell Leukemia Treatment Market Size by Application (2019-2024)
7.3.2 Europe Hairy cell Leukemia Treatment Market Size by Application (2025-2030)
7.3.3 Europe Hairy cell Leukemia Treatment Market Share by Application (2019-2030)
7.4 Europe Hairy cell Leukemia Treatment Market Size by Country
7.4.1 Europe Hairy cell Leukemia Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Hairy cell Leukemia Treatment Market Size by Country (2019-2024)
7.4.3 Europe Hairy cell Leukemia Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hairy cell Leukemia Treatment Market Size (2019-2030)
8.2 China Hairy cell Leukemia Treatment Market Size by Type
8.2.1 China Hairy cell Leukemia Treatment Market Size by Type (2019-2024)
8.2.2 China Hairy cell Leukemia Treatment Market Size by Type (2025-2030)
8.2.3 China Hairy cell Leukemia Treatment Market Share by Type (2019-2030)
8.3 China Hairy cell Leukemia Treatment Market Size by Application
8.3.1 China Hairy cell Leukemia Treatment Market Size by Application (2019-2024)
8.3.2 China Hairy cell Leukemia Treatment Market Size by Application (2025-2030)
8.3.3 China Hairy cell Leukemia Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Hairy cell Leukemia Treatment Market Size (2019-2030)
9.2 Asia Hairy cell Leukemia Treatment Market Size by Type
9.2.1 Asia Hairy cell Leukemia Treatment Market Size by Type (2019-2024)
9.2.2 Asia Hairy cell Leukemia Treatment Market Size by Type (2025-2030)
9.2.3 Asia Hairy cell Leukemia Treatment Market Share by Type (2019-2030)
9.3 Asia Hairy cell Leukemia Treatment Market Size by Application
9.3.1 Asia Hairy cell Leukemia Treatment Market Size by Application (2019-2024)
9.3.2 Asia Hairy cell Leukemia Treatment Market Size by Application (2025-2030)
9.3.3 Asia Hairy cell Leukemia Treatment Market Share by Application (2019-2030)
9.4 Asia Hairy cell Leukemia Treatment Market Size by Region
9.4.1 Asia Hairy cell Leukemia Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Hairy cell Leukemia Treatment Market Size by Region (2019-2024)
9.4.3 Asia Hairy cell Leukemia Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Hairy cell Leukemia Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Janssen Global Services
11.2.1 Janssen Global Services Company Details
11.2.2 Janssen Global Services Business Overview
11.2.3 Janssen Global Services Hairy cell Leukemia Treatment Introduction
11.2.4 Janssen Global Services Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.2.5 Janssen Global Services Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Details
11.3.2 Dr. Reddy's Laboratories Business Overview
11.3.3 Dr. Reddy's Laboratories Hairy cell Leukemia Treatment Introduction
11.3.4 Dr. Reddy's Laboratories Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.3.5 Dr. Reddy's Laboratories Recent Developments
11.4 Emcure Pharmaceuticals
11.4.1 Emcure Pharmaceuticals Company Details
11.4.2 Emcure Pharmaceuticals Business Overview
11.4.3 Emcure Pharmaceuticals Hairy cell Leukemia Treatment Introduction
11.4.4 Emcure Pharmaceuticals Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.4.5 Emcure Pharmaceuticals Recent Developments
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Hairy cell Leukemia Treatment Introduction
11.5.4 Amgen Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.5.5 Amgen Recent Developments
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Hairy cell Leukemia Treatment Introduction
11.6.4 Hospira Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.6.5 Hospira Recent Developments
11.7 Astex Therapeutics
11.7.1 Astex Therapeutics Company Details
11.7.2 Astex Therapeutics Business Overview
11.7.3 Astex Therapeutics Hairy cell Leukemia Treatment Introduction
11.7.4 Astex Therapeutics Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.7.5 Astex Therapeutics Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Hairy cell Leukemia Treatment Introduction
11.8.4 AbbVie Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.8.5 AbbVie Recent Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Hairy cell Leukemia Treatment Introduction
11.9.4 Astellas Pharma Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.9.5 Astellas Pharma Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Hairy cell Leukemia Treatment Introduction
11.10.4 AstraZeneca Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.10.5 AstraZeneca Recent Developments
11.11 Biogenomics
11.11.1 Biogenomics Company Details
11.11.2 Biogenomics Business Overview
11.11.3 Biogenomics Hairy cell Leukemia Treatment Introduction
11.11.4 Biogenomics Revenue in Hairy cell Leukemia Treatment Business (2019-2024)
11.11.5 Biogenomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Hairy cell Leukemia Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Chemotherapy Drugs Table 3. Key Players of Immunotherapy Drugs Table 4. Global Hairy cell Leukemia Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Hairy cell Leukemia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Hairy cell Leukemia Treatment Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Hairy cell Leukemia Treatment Market Share by Region (2019-2024) Table 8. Global Hairy cell Leukemia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Hairy cell Leukemia Treatment Market Share by Region (2025-2030) Table 10. Hairy cell Leukemia Treatment Market Trends Table 11. Hairy cell Leukemia Treatment Market Drivers Table 12. Hairy cell Leukemia Treatment Market Challenges Table 13. Hairy cell Leukemia Treatment Market Restraints Table 14. Global Hairy cell Leukemia Treatment Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Hairy cell Leukemia Treatment Revenue Share by Players (2019-2024) Table 16. Global Top Hairy cell Leukemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hairy cell Leukemia Treatment as of 2023) Table 17. Global Hairy cell Leukemia Treatment Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Hairy cell Leukemia Treatment Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Hairy cell Leukemia Treatment, Headquarters and Area Served Table 20. Global Key Players of Hairy cell Leukemia Treatment, Product and Application Table 21. Global Key Players of Hairy cell Leukemia Treatment, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hairy cell Leukemia Treatment Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Hairy cell Leukemia Treatment Revenue Market Share by Type (2019-2024) Table 25. Global Hairy cell Leukemia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Hairy cell Leukemia Treatment Revenue Market Share by Type (2025-2030) Table 27. Global Hairy cell Leukemia Treatment Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Hairy cell Leukemia Treatment Revenue Share by Application (2019-2024) Table 29. Global Hairy cell Leukemia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Hairy cell Leukemia Treatment Revenue Share by Application (2025-2030) Table 31. North America Hairy cell Leukemia Treatment Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Hairy cell Leukemia Treatment Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Hairy cell Leukemia Treatment Market Size by Application (2019-2024) & (US$ Million) Table 34. North America Hairy cell Leukemia Treatment Market Size by Application (2025-2030) & (US$ Million) Table 35. North America Hairy cell Leukemia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Hairy cell Leukemia Treatment Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Hairy cell Leukemia Treatment Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Hairy cell Leukemia Treatment Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Hairy cell Leukemia Treatment Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Hairy cell Leukemia Treatment Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe Hairy cell Leukemia Treatment Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe Hairy cell Leukemia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Hairy cell Leukemia Treatment Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Hairy cell Leukemia Treatment Market Size by Country (2025-2030) & (US$ Million) Table 45. China Hairy cell Leukemia Treatment Market Size by Type (2019-2024) & (US$ Million) Table 46. China Hairy cell Leukemia Treatment Market Size by Type (2025-2030) & (US$ Million) Table 47. China Hairy cell Leukemia Treatment Market Size by Application (2019-2024) & (US$ Million) Table 48. China Hairy cell Leukemia Treatment Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia Hairy cell Leukemia Treatment Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Hairy cell Leukemia Treatment Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Hairy cell Leukemia Treatment Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia Hairy cell Leukemia Treatment Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia Hairy cell Leukemia Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Hairy cell Leukemia Treatment Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Hairy cell Leukemia Treatment Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size by Country (2025-2030) & (US$ Million) Table 63. F. Hoffmann-La Roche Company Details Table 64. F. Hoffmann-La Roche Business Overview Table 65. F. Hoffmann-La Roche Hairy cell Leukemia Treatment Product Table 66. F. Hoffmann-La Roche Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 67. F. Hoffmann-La Roche Recent Developments Table 68. Janssen Global Services Company Details Table 69. Janssen Global Services Business Overview Table 70. Janssen Global Services Hairy cell Leukemia Treatment Product Table 71. Janssen Global Services Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 72. Janssen Global Services Recent Developments Table 73. Dr. Reddy's Laboratories Company Details Table 74. Dr. Reddy's Laboratories Business Overview Table 75. Dr. Reddy's Laboratories Hairy cell Leukemia Treatment Product Table 76. Dr. Reddy's Laboratories Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 77. Dr. Reddy's Laboratories Recent Developments Table 78. Emcure Pharmaceuticals Company Details Table 79. Emcure Pharmaceuticals Business Overview Table 80. Emcure Pharmaceuticals Hairy cell Leukemia Treatment Product Table 81. Emcure Pharmaceuticals Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 82. Emcure Pharmaceuticals Recent Developments Table 83. Amgen Company Details Table 84. Amgen Business Overview Table 85. Amgen Hairy cell Leukemia Treatment Product Table 86. Amgen Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 87. Amgen Recent Developments Table 88. Hospira Company Details Table 89. Hospira Business Overview Table 90. Hospira Hairy cell Leukemia Treatment Product Table 91. Hospira Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 92. Hospira Recent Developments Table 93. Astex Therapeutics Company Details Table 94. Astex Therapeutics Business Overview Table 95. Astex Therapeutics Hairy cell Leukemia Treatment Product Table 96. Astex Therapeutics Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 97. Astex Therapeutics Recent Developments Table 98. AbbVie Company Details Table 99. AbbVie Business Overview Table 100. AbbVie Hairy cell Leukemia Treatment Product Table 101. AbbVie Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 102. AbbVie Recent Developments Table 103. Astellas Pharma Company Details Table 104. Astellas Pharma Business Overview Table 105. Astellas Pharma Hairy cell Leukemia Treatment Product Table 106. Astellas Pharma Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 107. Astellas Pharma Recent Developments Table 108. AstraZeneca Company Details Table 109. AstraZeneca Business Overview Table 110. AstraZeneca Hairy cell Leukemia Treatment Product Table 111. AstraZeneca Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 112. AstraZeneca Recent Developments Table 113. Biogenomics Company Details Table 114. Biogenomics Business Overview Table 115. Biogenomics Hairy cell Leukemia Treatment Product Table 116. Biogenomics Revenue in Hairy cell Leukemia Treatment Business (2019-2024) & (US$ Million) Table 117. Biogenomics Recent Developments Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Global Hairy cell Leukemia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Hairy cell Leukemia Treatment Market Share by Type: 2023 VS 2030 Figure 3. Chemotherapy Drugs Features Figure 4. Immunotherapy Drugs Features Figure 5. Global Hairy cell Leukemia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Hairy cell Leukemia Treatment Market Share by Application: 2023 VS 2030 Figure 7. Hospitals Case Studies Figure 8. Pharmacies Case Studies Figure 9. Cancer Research Organization Case Studies Figure 10. Hairy cell Leukemia Treatment Report Years Considered Figure 11. Global Hairy cell Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 12. Global Hairy cell Leukemia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 13. Global Hairy cell Leukemia Treatment Market Share by Region: 2023 VS 2030 Figure 14. Global Hairy cell Leukemia Treatment Market Share by Players in 2023 Figure 15. Global Top Hairy cell Leukemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hairy cell Leukemia Treatment as of 2023) Figure 16. The Top 10 and 5 Players Market Share by Hairy cell Leukemia Treatment Revenue in 2023 Figure 17. North America Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 18. North America Hairy cell Leukemia Treatment Market Share by Type (2019-2030) Figure 19. North America Hairy cell Leukemia Treatment Market Share by Application (2019-2030) Figure 20. North America Hairy cell Leukemia Treatment Market Share by Country (2019-2030) Figure 21. United States Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. Canada Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. Europe Hairy cell Leukemia Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 24. Europe Hairy cell Leukemia Treatment Market Share by Type (2019-2030) Figure 25. Europe Hairy cell Leukemia Treatment Market Share by Application (2019-2030) Figure 26. Europe Hairy cell Leukemia Treatment Market Share by Country (2019-2030) Figure 27. Germany Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. France Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. U.K. Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Italy Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Russia Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. Nordic Countries Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. China Hairy cell Leukemia Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 34. China Hairy cell Leukemia Treatment Market Share by Type (2019-2030) Figure 35. China Hairy cell Leukemia Treatment Market Share by Application (2019-2030) Figure 36. Asia Hairy cell Leukemia Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 37. Asia Hairy cell Leukemia Treatment Market Share by Type (2019-2030) Figure 38. Asia Hairy cell Leukemia Treatment Market Share by Application (2019-2030) Figure 39. Asia Hairy cell Leukemia Treatment Market Share by Region (2019-2030) Figure 40. Japan Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. South Korea Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. China Taiwan Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. Southeast Asia Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. India Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Australia Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 47. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Share by Type (2019-2030) Figure 48. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Share by Application (2019-2030) Figure 49. Middle East, Africa, and Latin America Hairy cell Leukemia Treatment Market Share by Country (2019-2030) Figure 50. Brazil Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 51. Mexico Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Turkey Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Saudi Arabia Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. Israel Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. GCC Countries Hairy cell Leukemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. F. Hoffmann-La Roche Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 57. Janssen Global Services Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 58. Dr. Reddy's Laboratories Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 59. Emcure Pharmaceuticals Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 60. Amgen Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 61. Hospira Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 62. Astex Therapeutics Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 63. AbbVie Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 64. Astellas Pharma Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 65. AstraZeneca Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 66. Biogenomics Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2019-2024) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)